Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-101

Sonja Klebe, Pamela J. Sykes, Douglas J. Coster, Ravi Krishnan, Keryn Williams

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Background. Modification of a donor cornea by gene therapy ex vivo has potential to modulate irreversible rejection, the major cause of corneal graft failure. Our aim was to transfer the gene encoding mammalian IL-10 to ovine donor corneas and to determine subsequent orthotopic corneal allograft survival in an outbred sheep model. Methods. The replicative capacity of ovine corneal endothelium was determined by autoradiography after deliberate injury. A replication-defective adenovirus was used to deliver the lacZ reporter gene to ovine corneas and transfected corneas were organ-cultured in vitro to allow transfection efficiency, duration of reporter gene expression, and toxicity attributable to the vector to be determined. A cDNA encoding full-length ovine IL-10 was cloned into an adenoviral vector that was used to transfect donor corneas ex vivo before transplantation. Orthotopic penetrating corneal transplantation was performed in outbred sheep. Results. Sheep corneal endothelium was found to be essentially amitotic. Transfection of > 70% corneal endothelial cells was achieved with the viral vector and expression was maintained for 28 days in vitro. IL-10 mRNA was detectable in transfected, organ-cultured corneas for 21 days in vitro. Donor corneas transfected with cDNA encoding IL-10 showed significantly prolonged survival after penetrating keratoplasty (median 55 days, range 19 ≥300 days) compared with control corneas (median 20.5 days, range 18-32 days, P=0.011). Conclusion. Local gene therapy-mediated expression of the immunomodulatory cytokine IL-10 has the potential to reduce the incidence of corneal graft rejection and to prolong corneal allograft survival.

LanguageEnglish
Pages1214-1220
Number of pages7
JournalTransplantation
Volume71
Issue number9
DOIs
Publication statusPublished - 15 May 2001
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation

Cite this

Klebe, Sonja ; Sykes, Pamela J. ; Coster, Douglas J. ; Krishnan, Ravi ; Williams, Keryn. / Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-101 In: Transplantation. 2001 ; Vol. 71, No. 9. pp. 1214-1220.
@article{1cf1462133364231b524d27b2ca1ced4,
title = "Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-101",
abstract = "Background. Modification of a donor cornea by gene therapy ex vivo has potential to modulate irreversible rejection, the major cause of corneal graft failure. Our aim was to transfer the gene encoding mammalian IL-10 to ovine donor corneas and to determine subsequent orthotopic corneal allograft survival in an outbred sheep model. Methods. The replicative capacity of ovine corneal endothelium was determined by autoradiography after deliberate injury. A replication-defective adenovirus was used to deliver the lacZ reporter gene to ovine corneas and transfected corneas were organ-cultured in vitro to allow transfection efficiency, duration of reporter gene expression, and toxicity attributable to the vector to be determined. A cDNA encoding full-length ovine IL-10 was cloned into an adenoviral vector that was used to transfect donor corneas ex vivo before transplantation. Orthotopic penetrating corneal transplantation was performed in outbred sheep. Results. Sheep corneal endothelium was found to be essentially amitotic. Transfection of > 70{\%} corneal endothelial cells was achieved with the viral vector and expression was maintained for 28 days in vitro. IL-10 mRNA was detectable in transfected, organ-cultured corneas for 21 days in vitro. Donor corneas transfected with cDNA encoding IL-10 showed significantly prolonged survival after penetrating keratoplasty (median 55 days, range 19 ≥300 days) compared with control corneas (median 20.5 days, range 18-32 days, P=0.011). Conclusion. Local gene therapy-mediated expression of the immunomodulatory cytokine IL-10 has the potential to reduce the incidence of corneal graft rejection and to prolong corneal allograft survival.",
author = "Sonja Klebe and Sykes, {Pamela J.} and Coster, {Douglas J.} and Ravi Krishnan and Keryn Williams",
year = "2001",
month = "5",
day = "15",
doi = "10.1097/00007890-200105150-00006",
language = "English",
volume = "71",
pages = "1214--1220",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-101 . / Klebe, Sonja; Sykes, Pamela J.; Coster, Douglas J.; Krishnan, Ravi; Williams, Keryn.

In: Transplantation, Vol. 71, No. 9, 15.05.2001, p. 1214-1220.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-101

AU - Klebe, Sonja

AU - Sykes, Pamela J.

AU - Coster, Douglas J.

AU - Krishnan, Ravi

AU - Williams, Keryn

PY - 2001/5/15

Y1 - 2001/5/15

N2 - Background. Modification of a donor cornea by gene therapy ex vivo has potential to modulate irreversible rejection, the major cause of corneal graft failure. Our aim was to transfer the gene encoding mammalian IL-10 to ovine donor corneas and to determine subsequent orthotopic corneal allograft survival in an outbred sheep model. Methods. The replicative capacity of ovine corneal endothelium was determined by autoradiography after deliberate injury. A replication-defective adenovirus was used to deliver the lacZ reporter gene to ovine corneas and transfected corneas were organ-cultured in vitro to allow transfection efficiency, duration of reporter gene expression, and toxicity attributable to the vector to be determined. A cDNA encoding full-length ovine IL-10 was cloned into an adenoviral vector that was used to transfect donor corneas ex vivo before transplantation. Orthotopic penetrating corneal transplantation was performed in outbred sheep. Results. Sheep corneal endothelium was found to be essentially amitotic. Transfection of > 70% corneal endothelial cells was achieved with the viral vector and expression was maintained for 28 days in vitro. IL-10 mRNA was detectable in transfected, organ-cultured corneas for 21 days in vitro. Donor corneas transfected with cDNA encoding IL-10 showed significantly prolonged survival after penetrating keratoplasty (median 55 days, range 19 ≥300 days) compared with control corneas (median 20.5 days, range 18-32 days, P=0.011). Conclusion. Local gene therapy-mediated expression of the immunomodulatory cytokine IL-10 has the potential to reduce the incidence of corneal graft rejection and to prolong corneal allograft survival.

AB - Background. Modification of a donor cornea by gene therapy ex vivo has potential to modulate irreversible rejection, the major cause of corneal graft failure. Our aim was to transfer the gene encoding mammalian IL-10 to ovine donor corneas and to determine subsequent orthotopic corneal allograft survival in an outbred sheep model. Methods. The replicative capacity of ovine corneal endothelium was determined by autoradiography after deliberate injury. A replication-defective adenovirus was used to deliver the lacZ reporter gene to ovine corneas and transfected corneas were organ-cultured in vitro to allow transfection efficiency, duration of reporter gene expression, and toxicity attributable to the vector to be determined. A cDNA encoding full-length ovine IL-10 was cloned into an adenoviral vector that was used to transfect donor corneas ex vivo before transplantation. Orthotopic penetrating corneal transplantation was performed in outbred sheep. Results. Sheep corneal endothelium was found to be essentially amitotic. Transfection of > 70% corneal endothelial cells was achieved with the viral vector and expression was maintained for 28 days in vitro. IL-10 mRNA was detectable in transfected, organ-cultured corneas for 21 days in vitro. Donor corneas transfected with cDNA encoding IL-10 showed significantly prolonged survival after penetrating keratoplasty (median 55 days, range 19 ≥300 days) compared with control corneas (median 20.5 days, range 18-32 days, P=0.011). Conclusion. Local gene therapy-mediated expression of the immunomodulatory cytokine IL-10 has the potential to reduce the incidence of corneal graft rejection and to prolong corneal allograft survival.

UR - http://www.scopus.com/inward/record.url?scp=0035872802&partnerID=8YFLogxK

U2 - 10.1097/00007890-200105150-00006

DO - 10.1097/00007890-200105150-00006

M3 - Article

VL - 71

SP - 1214

EP - 1220

JO - Transplantation

T2 - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 9

ER -